Muda M, Theodosiou A, Gillieron C, Smith A, Chabert C, Camps M, Boschert U, Rodrigues N, Davies K, Ashworth A, Arkinstall S
Serono Pharmaceutical Research Institute, CH-1228 Plan-les-Ouates, Geneva, Switzerland.
J Biol Chem. 1998 Apr 10;273(15):9323-9. doi: 10.1074/jbc.273.15.9323.
We have reported recently that the dual specificity mitogen-activated protein kinase phosphatase-3 (MKP-3) elicits highly selective inactivation of the extracellular signal-regulated kinase (ERK) class of mitogen-activated protein (MAP) kinases (Muda, M., Theodosiou, A., Rodrigues, N., Boschert, U., Camps, M., Gillieron, C., Davies, K., Ashworth, A., and Arkinstall, S. (1996) J. Biol. Chem. 271, 27205-27208). We now show that MKP-3 enzymatic specificity is paralleled by tight binding to both ERK1 and ERK2 while, in contrast, little or no interaction with either c-Jun N-terminal kinase/stress activated protein kinase (JNK/SAPK) or p38 MAP kinases was detected. Further study revealed that the N-terminal noncatalytic domain of MKP-3 (MKP-3DeltaC) binds both ERK1 and ERK2, while the C-terminal MKP-3 catalytic core (MKP-3DeltaN) fails to precipitate either of these MAP kinases. A chimera consisting of the N-terminal half of MKP-3 with the C-terminal catalytic core of M3-6 also bound tightly to ERK1 but not to JNK3/SAPKbeta. Consistent with a role for N-terminal binding in determining MKP-3 specificity, at least 10-fold higher concentrations of purified MKP-3DeltaN than full-length MKP-3 is required to inhibit ERK2 activity. In contrast, both MKP-3DeltaN and full-length MKP-3 inactivate JNK/SAPK and p38 MAP kinases at similarly high concentrations. Also, a chimera of the M3-6 N terminus with the MKP-3 catalytic core which fails to bind ERK elicits non selective inactivation of ERK1 and JNK3/SAPKbeta. Together, these observations suggest that the physiological specificity of MKP-3 for inactivation of ERK family MAP kinases reflects tight substrate binding by its N-terminal domain.
我们最近报道,双特异性丝裂原活化蛋白激酶磷酸酶-3(MKP-3)能引发丝裂原活化蛋白(MAP)激酶的细胞外信号调节激酶(ERK)类的高度选择性失活(穆达,M.,西奥多西乌,A.,罗德里格斯,N.,博舍特,U.,坎普斯,M.,吉利隆,C.,戴维斯,K.,阿什沃思,A.,和阿金斯特尔,S.(1996年)《生物化学杂志》271,27205 - 27208)。我们现在表明,MKP-3的酶特异性与它和ERK1及ERK2的紧密结合相平行,而相比之下,未检测到它与c-Jun氨基末端激酶/应激激活蛋白激酶(JNK/SAPK)或p38 MAP激酶有任何相互作用。进一步研究发现,MKP-3的N末端非催化结构域(MKP-3DeltaC)能结合ERK1和ERK2,而C末端的MKP-3催化核心(MKP-3DeltaN)不能沉淀这两种MAP激酶中的任何一种。一个由MKP-3的N末端一半与M3-6的C末端催化核心组成的嵌合体也与ERK1紧密结合,但不与JNK3/SAPKbeta结合。与N末端结合在决定MKP-3特异性中所起的作用一致,抑制ERK2活性所需的纯化的MKP-3DeltaN的浓度比全长MKP-3至少高10倍。相比之下,MKP-3DeltaN和全长MKP-3在相似的高浓度下都能使JNK/SAPK和p38 MAP激酶失活。同样,一个由M3-6的N末端与MKP-3催化核心组成的不能结合ERK的嵌合体能引发ERK1和JNK3/SAPKbeta的非选择性失活。总之,这些观察结果表明,MKP-3对ERK家族MAP激酶失活的生理特异性反映了其N末端结构域与底物的紧密结合。